Convergent Genomics

San Francisco (CA)

Genomic liquid biopsy company leveraging cutting-edge data analytics to transform cancer care. UriSeq, a proprietary urine sequencing platform, enables actionable insights that are otherwise unattainable in today's clinical cancer management. Convergent Genomic's innovative solutions bring unprecedented clarity to clinical decision making by both outperforming current technology and introducing new paradigms to better detect, survey, and treat cancer.